Charles A. Sanders, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 2,000 shares at $5.22 ($10K) on 2012-03-13, disclosed to the SEC on 2012-03-15.
Open-market purchase of $10k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |
| VRTX | SELL | 2009-05-19 | $95K | — | Filing → |